Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Observation Only (Control)	45
Overall Study	STARTED	Imiquimod Only	45
Overall Study	STARTED	Imiquimod + 9-valent HPV Vaccine	43
Overall Study	Completed Treatment	Observation Only (Control)	45
Overall Study	Completed Treatment	Imiquimod Only	45
Overall Study	Completed Treatment	Imiquimod + 9-valent HPV Vaccine	43
Overall Study	Placed On Follow Up	Observation Only (Control)	29
Overall Study	Placed On Follow Up	Imiquimod Only	35
Overall Study	Placed On Follow Up	Imiquimod + 9-valent HPV Vaccine	28
Overall Study	COMPLETED	Observation Only (Control)	38
Overall Study	COMPLETED	Imiquimod Only	38
Overall Study	COMPLETED	Imiquimod + 9-valent HPV Vaccine	38
Overall Study	NOT COMPLETED	Observation Only (Control)	7
Overall Study	NOT COMPLETED	Imiquimod Only	7
Overall Study	NOT COMPLETED	Imiquimod + 9-valent HPV Vaccine	5

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02864147/flow